Published in Neurology on January 26, 2010
N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate. J Biol Chem (2011) 0.82
Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases. Biochim Biophys Acta (2010) 0.79
Infantile Sialic Acid Storage Disease: Two Unrelated Inuit Cases Homozygous for a Common Novel SLC17A5 Mutation. JIMD Rep (2013) 0.77
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet (1999) 1.76
Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology (2004) 1.10
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693. Br J Clin Pharmacol (2005) 1.06
The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain (2009) 0.94
Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene. Eur J Paediatr Neurol (2007) 0.93
N-acetylaspartylglutamate in Canavan disease: an adverse effector? Eur J Pediatr (1999) 0.90
N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher disease. Adv Exp Med Biol (2006) 0.88
Free sialic acid storage disease without sialuria. Ann Neurol (2009) 0.87
Cerebellar ataxia with elevated cerebrospinal free sialic acid (CAFSA). Brain (2009) 0.86
Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia. Brain Res (1998) 0.85
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science (1999) 7.13
Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet (1999) 4.92
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet (2009) 4.02
Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin. Proc Natl Acad Sci U S A (1998) 3.85
The frequency of lysosomal storage diseases in The Netherlands. Hum Genet (1999) 3.54
Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest (1997) 3.45
The mammalian sodium channel BNC1 is required for normal touch sensation. Nature (2000) 3.30
Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science (1998) 3.18
A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell (1995) 3.17
Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem (1998) 3.00
Mutator genes--pacemakers of evolution. Nature (1978) 2.72
Quantitative variation and gene number. Nature (1975) 2.68
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet (1998) 2.62
Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience (2007) 2.55
Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol (1997) 2.53
Structural mosaicism on the submicron scale in the plasma membrane. Biophys J (1998) 2.50
Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet (2000) 2.43
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med (1995) 2.39
MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol (2006) 2.38
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab (2003) 2.29
Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26
Parkinsonism among Gaucher disease carriers. J Med Genet (2004) 2.24
Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology (2006) 2.19
Specialist investigation of obscure gastrointestinal bleeding. Gut (1987) 2.10
VAMP-7 mediates vesicular transport from endosomes to lysosomes. J Cell Biol (1999) 2.01
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell (1995) 1.99
Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis (2006) 1.98
Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc Natl Acad Sci U S A (2000) 1.94
Is EBV persistence in vivo a model for B cell homeostasis? Immunity (1996) 1.94
Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem (1989) 1.91
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology (2007) 1.89
Performance of near-infrared spectroscopy in measuring local O(2) consumption and blood flow in skeletal muscle. J Appl Physiol (1985) (2001) 1.86
Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol (2006) 1.83
Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery. Dis Colon Rectum (2001) 1.82
Transport measurements across a tunable potential barrier in graphene. Phys Rev Lett (2007) 1.78
Multiple occurrences of mutualism in the yucca moth lineage. Proc Natl Acad Sci U S A (1992) 1.76
Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet (2007) 1.76
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain (2000) 1.75
Disturbance and the dispersal of fleshy fruits. Science (1978) 1.74
Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell (1988) 1.73
Radiofrequency map of an NMR coil by imaging. Magn Reson Imaging (1993) 1.69
GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology (2011) 1.69
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J (2003) 1.68
Enhancing the clinical research pipeline: training approaches for a new century. Acad Med (2001) 1.67
Three novel proteins of the syntaxin/SNAP-25 family. J Biol Chem (1998) 1.67
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem (1995) 1.67
Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology (1999) 1.67
The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology (2003) 1.66
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther (2001) 1.65
Presumptive control mutation for alcohol dehydrogenase in Drosophila melanogaster. Nature (1977) 1.64
Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking. Mol Biol Cell (1999) 1.64
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology (2000) 1.63
The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology (2004) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis (2000) 1.61
Which patients with suspected appendicitis should undergo laparoscopy? Br Med J (Clin Res Ed) (1988) 1.61
Intraspecific hybridisation and the release of mutator activity. Nature (1979) 1.60
Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta (1992) 1.59
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Subtle anomalies of the septum pellucidum and neurodevelopmental deficits. Dev Med Child Neurol (1994) 1.57
Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest (1999) 1.56
Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke (2001) 1.56
An ankyrin-related gene (unc-44) is necessary for proper axonal guidance in Caenorhabditis elegans. J Cell Biol (1995) 1.55
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend (2000) 1.55
False-positive findings on lumbar discography. Reliability of subjective concordance assessment during provocative disc injection. Spine (Phila Pa 1976) (1999) 1.54
Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A (1999) 1.53
Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat (2011) 1.53
Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice. J Clin Invest (1999) 1.52
MRI as diagnostic tool in early-onset peroxisomal disorders. Neurology (2012) 1.50
Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet (1993) 1.50
Age-related changes in the relative growth of the posterior fossa. J Child Neurol (1991) 1.48
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation (2001) 1.46
Obscure gastrointestinal haemorrhage of small-bowel origin. Br Med J (Clin Res Ed) (1984) 1.46
AvrXa10 contains an acidic transcriptional activation domain in the functionally conserved C terminus. Mol Plant Microbe Interact (1998) 1.45
Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr (2000) 1.45
Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest (2001) 1.45
Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology (2008) 1.45
Adipose tissue thickness affects in vivo quantitative near-IR spectroscopy in human skeletal muscle. Clin Sci (Lond) (2001) 1.45
Small bowel transit time in patients with intra-abdominal adhesions. Br J Surg (1992) 1.43
Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem (2003) 1.42
Bile duct stones and laparoscopic cholecystectomy. BMJ (1991) 1.42
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology (2001) 1.42
Transmembrane ICa contributes to rate-dependent changes of action potentials in human ventricular myocytes. Am J Physiol (1999) 1.42
Precision parameters of methods of analysis required for nutrition labeling. Part I. Major nutrients. J Assoc Off Anal Chem (1991) 1.42
Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen (1999) 1.41
Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest (1995) 1.41
Blackcurrant seed oil for prevention of atopic dermatitis in newborns: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy (2010) 1.41
Spontaneous Chromosome Breakage at Male Meiosis Associated with Male Recombination in DROSOPHILA MELANOGASTER. Genetics (1978) 1.40
A definition and standard nomenclature for "polygenic loci". Heredity (Edinb) (1974) 1.40
A review of the management of small bowel obstruction. Members of the Surgical and Clinical Adhesions Research Study (SCAR). Ann R Coll Surg Engl (1999) 1.40
Conditional Polygenic Effects in the Sternopleural Bristle System of DROSOPHILA MELANOGASTER. Genetics (1984) 1.38
Questionnaire identification of surgical patients at risk of HIV infection. J R Coll Surg Edinb (1990) 1.38
Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol (1991) 1.38
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet (2001) 1.36
Clusters of identical new mutation in the evolutionary landscape. Genetica (1996) 1.35
Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem (1992) 1.34
Hypomyelination with atrophy of the basal ganglia and cerebellum: follow-up and pathology. Neurology (2007) 1.34
A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A (1999) 1.33